<i>TIPE2</i> deletion improves the therapeutic potential of adoptively transferred NK cells

Jiacheng Bi, Chen Huang, Xiaomeng Jin, Chaoyue Zheng, Yingying Huang, Xiaohu Zheng, Zhigang Tian, Haoyu Sun

Open source

DOI
10.1136/jitc-2022-006002
Published
2023-02
Container
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2022-006002,
  title = {<i>TIPE2</i> deletion improves the therapeutic potential of adoptively transferred NK cells},
  author = {Jiacheng Bi and Chen Huang and Xiaomeng Jin and Chaoyue Zheng and Yingying Huang and Xiaohu Zheng and Zhigang Tian and Haoyu Sun},
  year = {2023},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2022-006002},
  url = {https://doi.org/10.1136/jitc-2022-006002}
}

RIS

TY  - JOUR
TI  - <i>TIPE2</i> deletion improves the therapeutic potential of adoptively transferred NK cells
AU  - Jiacheng Bi
AU  - Chen Huang
AU  - Xiaomeng Jin
AU  - Chaoyue Zheng
AU  - Yingying Huang
AU  - Xiaohu Zheng
AU  - Zhigang Tian
AU  - Haoyu Sun
PY  - 2023
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2022-006002
UR  - https://doi.org/10.1136/jitc-2022-006002
ER  - 

APA

Bi, J., Huang, C., Jin, X., Zheng, C., Huang, Y., Zheng, X., Tian, Z., & Sun, H. (2023). <i>TIPE2</i> deletion improves the therapeutic potential of adoptively transferred NK cells. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2022-006002

Source records